Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.33 USD | +0.38% |
|
+0.76% | -20.36% |
Jun. 20 | Transcript : Milestone Pharmaceuticals Inc. - Special Call | |
May. 29 | Milestone Pharmaceuticals Says US FDA Accepts New Drug Application for Cardamyst Nasal Spray for Arrhythmia | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.36% | 87.99M | |
+16.61% | 122B | |
+17.75% | 112B | |
+17.23% | 25.91B | |
-24.11% | 19.33B | |
-18.56% | 16.17B | |
-18.47% | 15.56B | |
-47.75% | 14.65B | |
+57.35% | 14.34B | |
+5.62% | 14B |
- Stock Market
- Equities
- MIST Stock
- News Milestone Pharmaceuticals Inc.
- TD Cowen Cuts Price Target on Milestone Pharmaceuticals to $9 From $17, Maintains Outperform Rating